Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®)

Alekna, Vidmantas; Kilaite, Justina; Tamulaitienė, Marija; Geerinck, Anton; Mastavičiūtė, Asta; Bruyère, Olivier; Reginster, Jean‐Yves; Beaudart, Charlotte

doi:10.1007/s41999-019-00208-x

Cited by 20 publications

(34 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…www.e-agmr.org low number of study population. Similar publications of validations of the SarQoL are available for the English, French, Dutch, Romanian, Polish, Lithuanian, Greek, and other language versions, [7][8][9][10]13,25) with similar results in terms of the reliability and validity of the SarQoL questionnaire.…”

Section: Discussionmentioning

confidence: 75%

“…5,7,8) The alpha value in our study was lower than those in the Greek, Lithuanian, Romanian, and Polish validation studies (0.960, 0.950, 0.946, and 0.920, respectively) suggesting that some questions in the SarQoL may be redundant. 9,10,13,25) However, although the internal consistency of the Ukrainian was excellent, this does not mean that cross-cultural effects are, therefore, excluded. Although we paid particular attention to cross-cultural equivalence, Ukrainian participants may have responded differently to certain questions.…”

Section: Discussionmentioning

confidence: 98%

“…Overall, the results have indicated that the SarQoL questionnaire is a reliable instrument. 25) The construct validity of the SarQoL-UA was examined with eight hypotheses on the correlation between the domains of the SF-36 and EQ-5D questionnaires that were theorized to measure a similar (convergent) or dissimilar (divergent) construct from that of the SarQoL-UA. The results showed that the questionnaire possessed good convergent validity; however, the results of the divergent validity were not as expected.…”

Section: Discussionmentioning

confidence: 99%

“…Test-retest reliability was excellent in our study and the same as reported in French, English, Dutch, Polish, Greek and Lithuanian studies. 6 - 8 , 10 , 13 , 25 ) The validation of the Romanian version did not perform test-retest reliability because of the limited number of sarcopenic subjects (n=13). Overall, the results have indicated that the SarQoL questionnaire is a reliable instrument.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Dzhus

Masnyi

Kulyk

et al. 2020

Ann Geriatr Med Res

Self Cite

View full text Add to dashboard Cite

Sarcopenia is a progressive and generalized loss of muscle mass and function with advancing age. 1,2) This geriatric syndrome is now considered an increasing public health issue worldwide. 3) Sarcopenia is associated with adverse health outcomes such as physical impairment, mobility limitations, increased fall risk, hospitalization, and mortality. 4) In the last decade, several sarcopenia definitions and proposals for diagnostic criteria have been published. Among these, the revised consensus criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2) appear to be the most promising. The EWGSOP2 considers sarcopenia to be present when a person presents with both low muscle strength and low muscle mass. Additionally, people with low physical performance are categorized as severely sarcopenic. 3) This condition can also impact patient quality of life. Since this aspect is not straightforward for clinical evaluation, the issue is less studied so far. The existing quality of life questionnaires, such as the Short Form 36 (SF-36) and EuroQoL 5-dimension (EQ-5D), are designed for use in a broad swath of health conditions and pa

show abstract

Section: Discussionmentioning

confidence: 75%

Section: Discussionmentioning

confidence: 98%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Dzhus

Masnyi

Kulyk

et al. 2020

Ann Geriatr Med Res

Self Cite

View full text Add to dashboard Cite

show abstract

“…The clinimetric properties of the SarQoL questionnaire have been examined for 11 language-specific versions of the questionnaire and has demonstrated strong measurement properties [9][10][11][12][13][14][15][16][17][18][19][20]. The questionnaire has been extensively translated, and is available in 30 languages from the website www.…”

Section: Introductionmentioning

confidence: 99%

Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

et al. 2021

View full text Add to dashboard Cite

Purpose To facilitate the measurement of quality of life in sarcopenia, we set out to reduce the number of items in the previously validated Sarcopenia Quality of Life (SarQoL®) questionnaire, and to evaluate the clinimetric properties of this new short form. Methods The item reduction process was carried out in two phases. First, information was gathered through item-impact scores from older people (n = 1950), a Delphi method with sarcopenia experts, and previously published clinimetric data. In the second phase, this information was presented to an expert panel that decided which of the items to include in the short form. The newly created SFSarQoL was then administered to older, community-dwelling participants who previously participated in the SarcoPhAge study. We examined discriminative power, internal consistency, construct validity, test–retest reliability, structural validity and examined item parameters with a graded response model (IRT). Results The questionnaire was reduced from 55 to 14 items, a 75% reduction. A total of 214 older, community-dwelling people were recruited for the validation study. The clinimetric evaluation showed that the SF-SarQoL® can discriminate on sarcopenia status [EWGSOP2 criteria; 34.52 (18.59–43.45) vs. 42.86 (26.56–63.69); p = 0.043], is internally consistent (α = 0.915, ω = 0.917) and reliable [ICC = 0.912 (0.847–0.942)]. A unidimensional model was fitted (CFI = 0.978; TLI = 0.975; RMSEA = 0.108, 90% CI 0.094–0.123; SRMR = 0.055) with no misfitting items and good response category separation. Conclusions A new, 14-item, short form version of the Sarcopenia Quality of Life questionnaire has been developed and shows good clinimetric properties.

show abstract

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL^® questionnaire

Geerinck

Locquet

Bruyère

et al. 2021

J cachexia sarcopenia muscle

Self Cite

View full text Add to dashboard Cite

Background The SarQoL® questionnaire was specifically designed to measure quality of life (QoL) in sarcopenia. Frailty and sarcopenia have areas of overlap, notably weak muscle strength and slow gait speed, which may mean that the SarQoL could provide a measure of QoL in frailty. This study aimed to evaluate the clinimetric properties of the SarQoL questionnaire in physical frailty using the Fried criteria. Methods Analyses were carried out on data from the Sarcopenia and Physical impairment with advancing Age study. Frailty was assessed with the Fried criteria and QoL with the SarQoL, the Short-Form 36-Item, and the EuroQoL 5-Dimension (EQ-5D) questionnaires. We evaluated discriminative power (with the Kruskal-Wallis analysis of variance test), internal consistency (with Cronbach's alpha), construct validity (through hypotheses testing), test-retest reliability (with the intraclass correlation coefficient), measurement error (calculating standard error of measurement and smallest detectable change), and responsiveness (through hypotheses testing and standardized response mean). Results In total, 382 participants were included for the validation and 117 for the responsiveness evaluation. They had a median age of 73 (69-79) years, took 5 (3-8) drugs, and had 4 (3-5) co-morbidities. There were more women (n = 223; 58.4%) than men and, in total, 172 (45%) robust, 167 (44%) pre-frail, and 43 (11%) frail participants. Discriminative power was confirmed when significantly lower (P < 0.001) overall SarQoL scores, and thus also worse QoL, were observed between robust [77.1 (64.35-85.90)], pre-frail [62.54 (53.33-69.57)], and frail [49.99 (40.45-56.06)] participants. Six of the SarQoL domains performed likewise, with significantly lower scores according to frailty status with Domain 7 (fears) being the exception. Internal consistency was good (α = 0.866). Convergent (using Short-Form 36-Item and EQ-5D) and divergent construct validity (using EQ-5D) was confirmed. Test-retest reliability was excellent [intraclass correlation coefficient = 0.918 (0.834-0.961)], with a standard error of measurement of 3.88 and a smallest detectable change of 10.76 points. We found moderate responsiveness when five of the nine hypotheses were confirmed, coupled with a large effect size for the overall SarQoL score (corrected standardized response mean of À1.44). Conclusions The SarQoL questionnaire has adequate clinimetric properties for use with frail patients in clinical practice and trials and could provide data that are more appropriate and detailed than the generic questionnaires currently used.

show abstract

Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®)

Cited by 20 publications

References 25 publications

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL^® questionnaire

Contact Info

Product

Resources

About

Validation of the Lithuanian version of sarcopenia-specific quality of life questionnaire (SarQoL®)

Cited by 20 publications

References 25 publications

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties

Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL® questionnaire

Contact Info

Product

Resources

About

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL^® questionnaire